Investigations into the etiology of neural tube defects.

Neural tube defects (NTDs) are serious malformations affecting approximately 1 per 1000 births, yet the mechanisms by which they arise are unknown. There have been consistent efforts in many fields of research to elucidate the etiology of this multifactorial condition. While no single gene has been identified as a major independent risk factor for NTDs, candidate genes have been proposed that may modify the effects of maternal and/or embryonic exposures. Folate supplementation effectively reduces the occurrence of NTDs and, consequently, has focused much research on metabolism of folate-related pathways during pregnancy and development. Further understanding of normal development and how teratogens can perturb these orchestrated processes also remains at the fore of modern scientific endeavors. The composite of these factors remains fragmented; the aim of this review is to provide the reader with a summary of sentinel and current works in the body of literature addressing NTD disease etiology.

[1]  Andrew J. Copp,et al.  The genetic basis of mammalian neurulation , 2003, Nature Reviews Genetics.

[2]  R. O’rahilly,et al.  The two sites of fusion of the neural folds and the two neuropores in the human embryo. , 2002, Teratology.

[3]  Andrew P. McMahon,et al.  Sonic hedgehog, a member of a family of putative signaling molecules, is implicated in the regulation of CNS polarity , 1993, Cell.

[4]  P. Venter,et al.  Congenital anomalies in rural black South African neonates--a silent epidemic? , 1995, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[5]  A. Ziegler,et al.  Evaluation of the MTHFR C677T allele and the MTHFR gene locus in a German spina bifida population , 1998, European Journal of Pediatrics.

[6]  S. Chirtel,et al.  Assessment of the embryotoxic potential of the total hydrolysis product of fumonisin B1 using cultured organogenesis-staged rat embryos. , 1997, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[7]  M. Khoury,et al.  Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case-control study. , 1990, Pediatrics.

[8]  D. W. Smith,et al.  Suggested limits to the use of the hot tub and sauna by pregnant women. , 1981, Canadian Medical Association journal.

[9]  G. Shaw,et al.  Neural tube and craniofacial defects with special emphasis on folate pathway genes. , 1998, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[10]  M. Kulldorff,et al.  Maternal supplemental and dietary zinc intake and the occurrence of neural tube defects in California. , 1999, American journal of epidemiology.

[11]  G. Shaw,et al.  Lack of association between mutations in the folate receptor-α gene and spina bifida , 1998 .

[12]  G. Rottinghaus,et al.  Developmental effects of fumonisin B1 in mice , 2004, Mycopathologia.

[13]  F. Rosa,et al.  Spina bifida in infants of women treated with carbamazepine during pregnancy. , 1991, The New England journal of medicine.

[14]  J. Olsen,et al.  The teratogenic risk of trimethoprim-sulfonamides: a population based case-control study. , 2001, Reproductive toxicology.

[15]  V. Stevens,et al.  Fumonisin B1-induced Sphingolipid Depletion Inhibits Vitamin Uptake via the Glycosylphosphatidylinositol-anchored Folate Receptor* , 1997, The Journal of Biological Chemistry.

[16]  A. Hunter,et al.  Neural tube defects in Eastern Ontario and Western Quebec: demography and family data. , 1984, American journal of medical genetics.

[17]  G. Oakley,et al.  High rates of neural tube defects in Ukraine. , 2004, Birth defects research. Part A, Clinical and molecular teratology.

[18]  L. Edmonds,et al.  Maternal fever and neural tube defects. , 1980, Teratology.

[19]  C. Ungley.  Vitamin B12 and other Dietary Factors in Megaloblastic Anaemias , 1950, British Journal of Nutrition.

[20]  R. Rozen.  Annotation Molecular genetics of methylenetetrahydrofolate reductase deficiency , 1996, Journal of Inherited Metabolic Disease.

[21]  E. Dawson,et al.  Amniotic Fluid B12, Calcium, and Lead Levels Associated with Neural Tube Defects , 1999, American journal of perinatology.

[22]  R. Walker,et al.  Effect of lithium carbonate on mouse and rat embryos in vitro. , 1990, Teratology.

[23]  R. Sprando,et al.  Effects of fumonisin B1 in pregnant rats. Part 2. , 1998, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[24]  B. Seetharam,et al.  Interaction of receptor for intrinsic factor-cobalamin complex with synthetic and brush-border lipids. , 1981, The Journal of biological chemistry.

[25]  J. Hirschhorn,et al.  A comprehensive review of genetic association studies , 2002, Genetics in Medicine.

[26]  M. Guenther,et al.  Histone Deacetylase Is a Direct Target of Valproic Acid, a Potent Anticonvulsant, Mood Stabilizer, and Teratogen* , 2001, The Journal of Biological Chemistry.

[27]  R. Finnell.  Genetic differences in susceptibility to anticonvulsant drug-induced developmental defects. , 1991, Pharmacology & toxicology.

[28]  P. Sparén,et al.  Risk factor patterns for cryptorchidism and hypospadias. , 1999, Epidemiology.

[29]  M. Lucock,et al.  Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. , 2000, Molecular genetics and metabolism.

[30]  J. M. Sequeira,et al.  Autoantibodies against folate receptors in women with a pregnancy complicated by a neural-tube defect. , 2004, The New England journal of medicine.

[31]  M. Loeken,et al.  Neural Tube Defects in Embryos of Diabetic Mice: Role of the Pax-3 Gene and Apoptosis , 1997, Diabetes.

[32]  G. Shaw,et al.  Gene-nutrient interactions: importance of folates and retinoids during early embryogenesis. , 2004, Toxicology and applied pharmacology.

[33]  S. Ceylan,et al.  Valproic acid sodium-induced spina bifida occulta in the rat , 2001, Neurosurgical Review.

[34]  C Y Ou,et al.  5,10 Methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. , 1996, American journal of medical genetics.

[35]  M. Harris.  Why are the genes that cause risk of human neural tube defects so hard to find? , 2001, Teratology.

[36]  K. Jones,et al.  Maternal fever and birth outcome: a prospective study. , 1998, Teratology.

[37]  L. Kilham,et al.  Exencephaly in fetal hamsters following exposure to hyperthermia. , 1976, Teratology.

[38]  Z. Li,et al.  Elevated rates of severe neural tube defects in a high-prevalence area in northern China. , 1997, American journal of medical genetics.

[39]  F. Alderuccio,et al.  Animal models of human disease: experimental autoimmune gastritis--a model for autoimmune gastritis and pernicious anemia. , 2002, Clinical immunology.

[40]  K. Lie,et al.  MORTALITY REDUCTION IN ISIS-2 TOO OPTIMISTIC BECAUSE OF UNSTABLE ANGINA? , 1988, The Lancet.

[41]  A. Merrill,et al.  Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme. , 1991, The Journal of biological chemistry.

[42]  N. Myrianthopoulos,et al.  Studies in neural tube defects. I. Epidemiologic and etiologic aspects. , 1987, American journal of medical genetics.

[43]  M Vrijheid,et al.  Risk of congenital anomalies near hazardous-waste landfill sites in Europe: the EUROHAZCON study , 1998, The Lancet.

[44]  W. Franklin,et al.  The folate-binding protein of rat kidney. Purification, properties, and cellular distribution. , 1984, The Journal of biological chemistry.

[45]  G. Shaw,et al.  Neural tube defects associated with maternal periconceptional dietary intake of simple sugars and glycemic index. , 2003, The American journal of clinical nutrition.

[46]  R. Finnell,et al.  Embryonic development of folate binding protein‐1 (Folbp1) knockout mice: Effects of the chemical form, dose, and timing of maternal folate supplementation , 2004, Developmental dynamics : an official publication of the American Association of Anatomists.

[47]  M. Gos,et al.  Genetic basis of neural tube defects. II. Genes correlated with folate and methionine metabolism. , 2002, Journal of applied genetics.

[48]  J. Klotz,et al.  Neural tube defects and drinking water disinfection by-products. , 1999, Epidemiology.

[49]  N. Wald,et al.  Blood folic acid and vitamin B12 in relation to neural tube defects , 1996, British journal of obstetrics and gynaecology.

[50]  D. Cockroft,et al.  Effects of hyperthermia on rat embryos in culture , 1975, Nature.

[51]  M. Seller,et al.  Amniotic fluid folate, vitamin B12 and transcobalamins in neural tube defects , 1988, Clinical genetics.

[52]  K. Volcik,et al.  Testing for genetic associations with the PAX gene family in a spina bifida population. , 2002, American journal of medical genetics.

[53]  D. Stumpo,et al.  MARCKS deficiency in mice leads to abnormal brain development and perinatal death. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[54]  S. Mayor,et al.  GPI anchoring leads to sphingolipid‐dependent retention of endocytosed proteins in the recycling endosomal compartment , 2001, The EMBO journal.

[55]  M. Wright.  A case-control study of maternal nutrition and neural tube defects in Northern Ireland. , 1995, Midwifery.

[56]  K. Shiota,et al.  Neural tube defects and maternal hyperthermia in early pregnancy: epidemiology in a human embryo population. , 1982, American journal of medical genetics.

[57]  The biological chemistry of folate receptors. , 1992 .

[58]  T. O'brien,et al.  Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis. , 2001, QJM : monthly journal of the Association of Physicians.

[59]  R. Finnell,et al.  Genetic background: the elusive component in the fetal hydantoin syndrome. , 1984, American journal of medical genetics.

[60]  É. Élefant,et al.  Hierarchization of animal teratology findings for improving the human risk evaluation of drugs. , 2000, Reproductive toxicology.

[61]  S Selvin,et al.  Maternal Residential Proximity to Hazardous Waste Sites and Risk for Selected Congenital Malformations , 1997, Epidemiology.

[62]  G. Shaw,et al.  Maternal illness, including fever and medication use as risk factors for neural tube defects. , 1998, Teratology.

[63]  D. Dennis,et al.  Surveillance for Lyme disease--United States, 1992-1998. , 2000, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[64]  J. Ross,et al.  Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications , 1994, Cancer.

[65]  K. Hendricks,et al.  Diarrhea: a new risk factor for neural tube defects? , 2003, Birth defects research. Part A, Clinical and molecular teratology.

[66]  S. Beck.  Contributions of dam and conceptus to differences in sensitivity to valproic acid among C57 black and SWV mice. , 1999, Reproductive toxicology.

[67]  S. Schwartz,et al.  Congenital malformations in newborns of women with established and gestational diabetes in Washington State, 1984-91. , 1996, Paediatric and perinatal epidemiology.

[68]  C. Johnson,et al.  An in ovo chicken model to study the systemic and localized teratogenic effects of valproic acid. , 2002, Teratology.

[69]  W. J. Oakes,et al.  Genetic Studies in Neural Tube Defects , 2000, Pediatric Neurosurgery.

[70]  M. den Heyer,et al.  Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida , 1995, The Lancet.

[71]  Quanhe Yang,et al.  5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. , 2000, American journal of epidemiology.

[72]  R. Finnell,et al.  Mapping a chromosomal locus for valproic acid-inducedexencephaly in mice , 2004, Mammalian Genome.

[73]  E. Ritzén.  Early Puberty: What Is Normal and When Is Treatment Indicated? , 2003, Hormone Research in Paediatrics.

[74]  A. Hofman,et al.  Antiepileptic drug regimens and major congenital abnormalities in the offspring , 1999, Annals of neurology.

[75]  J. Ray,et al.  Prevention and Detection of Diabetic Embryopathy , 2002, Public Health Genomics.

[76]  R. T. Lie,et al.  Risk of selected birth defects by maternal residence close to power lines during pregnancy , 2004, Occupational and Environmental Medicine.

[77]  N. L. Fisher,et al.  Occipital encephalocele and early gestational hyperthermia. , 1981, Pediatrics.

[78]  P. Howard,et al.  Lack of embryotoxicity of fumonisin B1 in New Zealand white rabbits. , 1997, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[79]  M. Cogswell,et al.  Maternal occupational and hobby chemical exposures as risk factors for neural tube defects. , 1999 .

[80]  G. Schoenwolf.  Histological and ultrastructural studies of secondary neurulation in mouse embryos. , 1984, The American journal of anatomy.

[81]  M. Fulcomer,et al.  Public drinking water contamination and birth outcomes. , 1995, American journal of epidemiology.

[82]  Douglas H. Evans,et al.  Amniotic Fluid B12 And Folate Levels Associated with Neural Tube Defects , 1998, American journal of perinatology.

[83]  M. Collins,et al.  Pax3 and the splotch mutations: structure, function, and relationship to teratogenesis, including gene-chemical interactions. , 2001, Current pharmaceutical design.

[84]  R. Rozen,et al.  Evaluation of genetic variants in the reduced folate carrier and in glutamate carboxypeptidase II for spina bifida risk. , 2003, Molecular genetics and metabolism.

[85]  M. Scott,et al.  Altered neural cell fates and medulloblastoma in mouse patched mutants. , 1997, Science.

[86]  D. Stone,et al.  Lead levels in domestic water supplies and neural tube defects in Glasgow , 2000, Archives of disease in childhood.

[87]  Synergy between asbestos and smoking on lung cancer risks. , 1999 .

[88]  U. Eriksson,et al.  Induction of embryonic dysmorphogenesis by high glucose concentration, disturbed inositol metabolism, and inhibited protein kinase C activity. , 2001, Teratology.

[89]  Lammer Ej,et al.  Teratogen update: valproic acid. , 1987, Teratology.

[90]  M. Loeken,et al.  Polymorphic susceptibility to the molecular causes of neural tube defects during diabetic embryopathy. , 2002, Diabetes.

[91]  E. Mariman,et al.  PAX genes and human neural tube defects: an amino acid substitution in PAX1 in a patient with spina bifida. , 1996, Journal of medical genetics.

[92]  K. Hendricks,et al.  Maternal Stress, Social Support, and Risk of Neural Tube Defects Among Mexican Americans , 2003, Epidemiology.

[93]  L. Saxén,et al.  Sauna and congenital defects. , 1982, Teratology.

[94]  A. Zimmerman.  Hyperzincemia in anencephaly and spina bifida , 1984, Neurology.

[95]  K. Vrana,et al.  Fundamentals of DNA hybridization arrays for gene expression analysis. , 2000, BioTechniques.

[96]  G M Shaw,et al.  Genetic Basis of Susceptibility to Environmentally Induced Neural Tube Defects , 2000, Annals of the New York Academy of Sciences.

[97]  M. Edwards,et al.  Congenital malformations in the rat following induced hyperthermia during gestation. , 1968, Teratology.

[98]  M. Forman,et al.  Maternal vitamin levels during pregnancies producing infants with neural tube defects. , 1992, The Journal of pediatrics.

[99]  G. Shaw,et al.  Analysis of select folate pathway genes, PAX3, and human T in a Midwestern neural tube defect population. , 1999, Teratology.

[100]  G M Shaw,et al.  Adverse human reproductive outcomes and electromagnetic fields: a brief summary of the epidemiologic literature. , 2001, Bioelectromagnetics.

[101]  G. Schoenwolf,et al.  Histological and ultrastructural studies on the origin of caudal neural crest cells in mouse embryos , 1984, The Journal of comparative neurology.

[102]  K. Hendricks,et al.  Parental Occupation and Neural Tube Defect–Affected Pregnancies Among Mexican Americans , 2002, Journal of occupational and environmental medicine.

[103]  E. Gunter,et al.  Maternal serum B12 levels and risk for neural tube defects in a Texas-Mexico border population. , 2003, Annals of epidemiology.

[104]  F. J. Garcia-Palmer,et al.  Uptake of myo-Inositol by Early-Somite Rat Conceptus: Transport Kinetics and Effects of Hyperglycemia , 1990, Diabetes.

[105]  M. Edwards.  Hyperthermia as a teratogen: a review of experimental studies and their clinical significance. , 1986, Teratogenesis, carcinogenesis, and mutagenesis.

[106]  H. Blom,et al.  Single nucleotide polymorphisms in the transcobalamin gene: relationship with transcobalamin concentrations and risk for neural tube defects , 2002, European Journal of Human Genetics.

[107]  G. Plant,et al.  Symptomatic retrochiasmal lesions in multiple sclerosis , 1992, Neurology.

[108]  E. Reece,et al.  Diabetic embryopathy: pathogenesis, prenatal diagnosis and prevention. , 1986, Obstetrical & gynecological survey.

[109]  Alfred H. Merrill,et al.  De Novo Sphingolipid Biosynthesis: A Necessary, but Dangerous, Pathway* , 2002, The Journal of Biological Chemistry.

[110]  H. Yang,et al.  Neural tube defects in Beijing-Tianjin area of China. Urban-rural distribution and some other epidemiological characteristics. , 1987, Journal of epidemiology and community health.

[111]  K. Shiota,et al.  Spatial and temporal expression of folate‐binding protein 1 (Fbp1) is closely associated with anterior neural tube closure in mice , 2002, Developmental dynamics : an official publication of the American Association of Anatomists.

[112]  Prevention of neural tube defects: Results of the Medical Research Council vitamin study , 1991 .

[113]  J. Friedman,et al.  Medical genetics: 1. Clinical teratology in the age of genomics. , 2002, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[114]  A. Coldman,et al.  Water composition in the etiology of anencephalus. , 1981, American journal of epidemiology.

[115]  F. Welsch.  In vitro approaches to the elucidation of mechanisms of chemical teratogenesis. , 1992, Teratology.

[116]  B. S. Cohen,et al.  ORAL TREATMENT OF PERNICIOUS ANEMIA WITH VITAMIN B12* † , 1950, The American journal of the medical sciences.

[117]  G. Shaw,et al.  Infant C677T mutation in MTHFR, maternal periconceptional vitamin use, and cleft lip. , 1998, American journal of medical genetics.

[118]  R. Rozen,et al.  A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. , 1998, Molecular genetics and metabolism.

[119]  G. Shaw,et al.  Maternal pesticide exposure from multiple sources and selected congenital anomalies. , 1999 .

[120]  R. Finnell,et al.  Reduced folate carrier polymorphism (80A→G) and neural tube defects , 2003, European Journal of Human Genetics.

[121]  P. Bosco,et al.  Transcobalamin and methionine synthase reductase mutated polymorphisms aggravate the risk of neural tube defects in humans , 2003, Neuroscience Letters.

[122]  A. Hofman,et al.  Maternal Use of Antiepileptic Drugs and the Risk of Major Congenital Malformations: A Joint European Prospective Study of Human Teratogenesis Associated with Maternal Epilepsy , 1997, Epilepsia.

[123]  F. Gabreëls,et al.  A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? , 1998, American journal of human genetics.

[124]  A. Boddie,et al.  Neural‐tube defects are associated with low concentrations of cobalamin (vitamin B12) in amniotic fluid , 1998, Prenatal diagnosis.

[125]  M. Pearce,et al.  Gene–gene interaction in folate-related genes and risk of neural tube defects in a UK population , 2004, Journal of Medical Genetics.

[126]  James M. Robins,et al.  Causal diagrams for epidemiologic research. , 1999 .

[127]  P. Zeitz,et al.  Drinking water contaminants and adverse pregnancy outcomes: a review. , 2002, Environmental health perspectives.

[128]  N. Greene,et al.  Inositol prevents folate-resistant neural tube defects in the mouse , 1997, Nature Medicine.

[129]  E. Mariman,et al.  Absence of linkage between familial neural tube defects and PAX3 gene. , 1995, Journal of medical genetics.

[130]  K. Shiota,et al.  Neural tube closure in humans initiates at multiple sites: evidence from human embryos and implications for the pathogenesis of neural tube defects , 2000, Anatomy and Embryology.

[131]  H. Blom,et al.  Vitamin B12 insufficiency and the risk of fetal neural tube defects. , 2003, QJM : monthly journal of the Association of Physicians.

[132]  M. J. Harris,et al.  Mouse models for neural tube closure defects. , 2000, Human molecular genetics.

[133]  A. Antony,et al.  Isolation, characterization, and comparison of the solubilized particulate and soluble folate binding proteins from human milk. , 1982, The Journal of biological chemistry.

[134]  V S Caviness,et al.  The adhesion signaling molecule p190 RhoGAP is required for morphogenetic processes in neural development. , 2000, Development.

[135]  P. Mastroiacovo,et al.  Exploring gene—gene interactions in the etiology of neural tube defects , 1998, Clinical genetics.

[136]  Y. Amitai,et al.  Surveillance of neural tube defects in Israel. , 2002, The Israel Medical Association journal : IMAJ.

[137]  G. Shaw,et al.  Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida. , 2002, American journal of medical genetics.

[138]  W. Webster,et al.  Hyperthermia as a teratogen: parameters determining hyperthermia-induced head defects in the rat. , 1985, Teratology.

[139]  E. Czeizel,et al.  The use of drugs in mothers of offspring with neural‐tube defects , 2004, Pharmacoepidemiology and drug safety.

[140]  G. Shaw,et al.  Evaluation of infant methylenetetrahydrofolate reductase genotype, maternal vitamin use, and risk of high versus low level spina bifida defects. , 2003, Birth defects research. Part A, Clinical and molecular teratology.

[141]  W. Willett,et al.  Maternal zinc and fetal neural tube defects. , 1992, Teratology.

[142]  D. Grobbee,et al.  The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort. , 1992, Neurology.

[143]  B. Källén,et al.  Congenital malformations among infants whose mothers had gestational diabetes or preexisting diabetes. , 2001, Early human development.

[144]  E. Mariman,et al.  Molecular genetic analysis of the gene encoding the trifunctional enzyme MTHFD (methylenetetrahydrofolate‐dehydrogenase, methenyltetrahydrofolate‐cyclohydrolase, formyltetrahydrofolate synthetase) in patients with neural tube defects , 1998, Clinical genetics.

[145]  I. V. van Rooij,et al.  Marginal maternal vitamin B12 status increases the risk of offspring with spina bifida. , 2004, American journal of obstetrics and gynecology.

[146]  B. Shane.  FOLATE CHEMISTRY AND METABOLISM* , 2001 .

[147]  P. Stover,et al.  Heavy Chain Ferritin Enhances Serine Hydroxymethyltransferase Expression and de Novo Thymidine Biosynthesis* , 2001, The Journal of Biological Chemistry.

[148]  D. Weir,et al.  Maternal serum folate and vitamin B12 concentrations in pregnancies associated with neural tube defects. , 1985, Archives of disease in childhood.

[149]  S. Beck.  Does genomic imprinting contribute to valproic acid teratogenicity? , 2001, Reproductive toxicology.

[150]  P. Pennell.  The importance of monotherapy in pregnancy , 2003, Neurology.

[151]  T. Yoshizawa,et al.  Comparative study on the natural occurrence of Fusarium mycotoxins (trichothecenes and zearalenone) in corn and wheat from high- and low-risk areas for human esophageal cancer in China , 1990, Applied and environmental microbiology.

[152]  K. Hendricks,et al.  Effects of Hyperinsulinemia and Obesity on Risk of Neural Tube Defects among Mexican Americans , 2001, Epidemiology.

[153]  S. Shapiro,et al.  Prepregnant weight in relation to risk of neural tube defects. , 1996, JAMA.

[154]  Steve Selvin,et al.  Dieting behaviors and risk of neural tube defects. , 2003, American journal of epidemiology.

[155]  Maternal heat exposure and neural tube defects. , 1992, JAMA.

[156]  L. L. Smith,et al.  Key challenges for toxicologists in the 21st century. , 2001, Trends in pharmacological sciences.

[157]  D. Gurwitz,et al.  Animal models and human genome diversity: the pitfalls of inbred mice. , 2001, Drug discovery today.

[158]  M. Khoury,et al.  Maternal flu, fever, and the risk of neural tube defects: a population-based case-control study. , 1994, American journal of epidemiology.

[159]  M. Marazita,et al.  Neural tube defects, methylenetetrahydrofolate reductase mutation, and north/south dietary differences in China. , 1998, Journal of craniofacial genetics and developmental biology.

[160]  S. Missmer,et al.  Fumonisins disrupt sphingolipid metabolism, folate transport, and neural tube development in embryo culture and in vivo: a potential risk factor for human neural tube defects among populations consuming fumonisin-contaminated maize. , 2004, The Journal of nutrition.

[161]  V. Ganapathy,et al.  Selective expression of the high-affinity isoform of the folate receptor (FR-alpha) in the human placental syncytiotrophoblast and choriocarcinoma cells. , 1994, Biochimica et biophysica acta.

[162]  A. Czeizel,et al.  Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin Supplementation , 1992 .

[163]  F. Fraser,et al.  POSSIBLE TERATOGENICITY OF MATERNAL FEVER , 1978, The Lancet.

[164]  R. Birch,et al.  Nutrient levels in amniotic fluid from women with normal and neural tube defect pregnancies. , 1992, Biology of the neonate.

[165]  C Lau,et al.  Biologically based risk assessment models for developmental toxicity. , 2000, Methods in molecular biology.

[166]  Why race is differentially classified on U.S. birth and infant death certificates: an examination of two hypotheses. , 1999 .

[167]  V. Stevens,et al.  Prevention of fumonisin B1-induced neural tube defects by folic acid. , 2002, Teratology.

[168]  D. Weir,et al.  Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. , 1993, The Quarterly journal of medicine.

[169]  R. Finnell,et al.  Polymorphisms in genes involved in folate metabolism as risk factors for NTDs. , 2001, European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie.

[170]  G. Shaw,et al.  PERICONCEPTIONAL VITAMIN USE, DIETARY FOLATE, AND THE OCCURRENCE OF NEURAL TUBE DEFECTS , 1995, Epidemiology.

[171]  W. King,et al.  Relation between trihalomethane compounds and birth defects , 2001, Occupational and environmental medicine.

[172]  A. Copp,et al.  Disruption of scribble (Scrb1) causes severe neural tube defects in the circletail mouse. , 2003, Human molecular genetics.

[173]  D. Williams,et al.  Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis. , 2001, Environmental health perspectives.

[174]  B. Seetharam,et al.  Isolation and characterization of the ileal receptor for intrinsic factor-cobalamin. , 1981, The Journal of biological chemistry.

[175]  L. Jovanovic-Peterson,et al.  Abnormal Metabolism and the Risk for Birth Defects with Emphasis on Diabetes , 1993, Annals of the New York Academy of Sciences.

[176]  J. Golden,et al.  Strain differences in heat-induced neural tube defects in mice. , 1986, Teratology.

[177]  Richard G. W. Anderson,et al.  Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development , 1999, Nature Genetics.

[178]  G. Bennett,et al.  Common hierarchies of susceptibility to the induction of neural tube defects in mouse embryos by valproic acid and its 4-propyl-4-pentenoic acid metabolite. , 1988, Teratology.

[179]  Ping Zhu,et al.  Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells , 2001, The EMBO journal.

[180]  R. Wilroy,et al.  MATERNAL HYPERTHERMIA AND NEURAL-TUBE DEFECTS , 1978, The Lancet.

[181]  J. Burn,et al.  Susceptibility to spina bifida; an association study of five candidate genes , 1998, Annals of human genetics.

[182]  G. Shaw,et al.  Risk of neural tube defect-affected pregnancies among obese women. , 1996, JAMA.

[183]  J. Simpson,et al.  Are obese women at higher risk for producing malformed offspring? , 1994, American journal of obstetrics and gynecology.

[184]  J. Graham,et al.  Central nervous system and facial defects associated with maternal hyperthermia at four to 14 weeks' gestation. , 1981, Pediatrics.

[185]  E. L. Fernández,et al.  Disturbing endoderm signaling to anterior neural plate of vertebrates by the teratogen cadmium. , 2004, Reproductive toxicology.

[186]  D. Chitayat,et al.  Evidence for multi-site closure of the neural tube in humans. , 1993, American journal of medical genetics.

[187]  S. Hernández-Díaz,et al.  Neural tube defects in relation to use of folic acid antagonists during pregnancy. , 2001, American journal of epidemiology.

[188]  K. Otani,et al.  Malformation in infants of mothers with epilepsy receiving antiepileptic drugs. , 1992, Neurology.